BioLine RX Ltd
F:YP2A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BioLine RX Ltd
F:YP2A
|
IL |
|
W
|
World Flex PCL
SET:WFX
|
TH |
|
Grenevia SA
F:8MF
|
PL |
|
A
|
Asset World Corp PCL
SET:AWC
|
TH |
|
Fortinet Inc
NASDAQ:FTNT
|
US |
|
Biogen Inc
NASDAQ:BIIB
|
US |
|
Abbvie Inc
NYSE:ABBV
|
US |
|
Regal Partners Ltd
F:OC7
|
AU |
|
Camden Property Trust
NYSE:CPT
|
US |
|
A
|
aTyr Pharma Inc
F:471A
|
US |
Shareholder Yield
Current shareholder yield for YP2A is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
YP2A Price
BioLine RX Ltd
| Average Annual Return | 21.86% |
| Standard Deviation of Annual Returns | 122.11% |
| Max Drawdown | -100% |
| Market Capitalization | 34.4m EUR |
| Shares Outstanding | 79 939 296 |
| Percentage of Shares Shorted |
N/A
|
YP2A Return Decomposition
Main factors of price return
Stock Splits
YP2A's latest stock split occurred on Jan 30, 2025
The company executed a 1-for-40 stock split, meaning that for every 40 shares held, investors received 1 new share.
Before the split, YP2A traded at 0.0745 per share. Afterward, the share price was about 2.98.
The adjusted shares began trading on Jan 30, 2025. This was stock split number 2 in YP2A's history, following the previous one in Jul 15, 2019.
